Hong Kong Stocks Moves Differently | Huabo Pharmaceuticals-B (02142.HK) Surges More than 7% During Trading, Wins Lawsuit Against Annjinn for Patent Infringement, Could Receive Up to $60.6 Million in Compensation.

According to the Securities Times APP, Haplo Biomedical-B (02142.HK) surged more than 7% in midday trading, up 6.48% as of the time of writing, to 10.68 Hong Kong dollars, with a turnover of 22.86 million Hong Kong dollars.